Instituto de Investigaciones Clínicas Quilmes
El “Instituto de Investigaciones Clínicas Quilmes SRL” es una institución, abocada exclusivamente a la realización de Estudios clínicos de fases II, III y IV. Contamos con staff con amplia experiencia en estudios de investigación clínica en diversas especialidades, tanto en internación como ambulatorios. Realizamos entrenamientos y capacitación continua al personal del sitio, más de 20 años de trabajo en el área nos avalan. El sitio se encuentra Ubicado en la calle Sarmiento 315, del partido de Quilmes (B1878GEG), en la provincia de Buenos Aires, en la República de Argentina.Sarmiento 315, Quilmes, Buenos Aires, Argentina
Select an option
I am a doctor
I am a sponsor
Specializations
Lupus eritematoso sistémico
Colitis ulcerosa
Our team
Medical staff
Maria Sapoznik
Jose Luis Velasco Zamora
Paola Andrea Adami
Adrian Hrabar
Alberto Fernández
Gustavo Medina
Yamila Chichotky
Adrian Lescano
Yamila R Chichotky
Open studies
Lupus
A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus - TOPAZ-2 - BiogenSee more
A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE) - POETYK SLE-1 - Bristol-Myers SquibbSee more
A Study to Assess the Efficacy and Safety of BIIB059 (Litifilimab) in Participants With Active Subacute Cutaneous Lupus Erythematosus (SCLE) and/or Chronic Cutaneous Lupus Erythematosus (CCLE) With or Without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy - AMETHYST - BiogenSee more
Ulcerative colitis
A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3) - LUCENT 3 - Eli Lilly and CompanySee more
Cardiovascular disease
Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease - VICTORION-2P - Novartis PharmaceuticalsSee more
Hypercholesterolemia
Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease - VICTORION-2P - Novartis PharmaceuticalsSee more
